Evermay Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57K | Buy |
150
+90
| +150% | +$1.54K | ﹤0.01% | 494 |
|
|
2025
Q1 | $3.83K | Hold |
60
| – | – | ﹤0.01% | 495 |
|
|
2024
Q4 | $7.3K | Hold |
60
| – | – | ﹤0.01% | 469 |
|
|
2024
Q3 | $7.49K | Hold |
60
| – | – | ﹤0.01% | 479 |
|
|
2024
Q2 | $9.48K | Hold |
60
| – | – | ﹤0.01% | 461 |
|
|
2024
Q1 | $7.77K | Hold |
60
| – | – | ﹤0.01% | 487 |
|
|
2023
Q4 | $5.79K | Hold |
60
| – | – | ﹤0.01% | 479 |
|
|
2023
Q3 | $7.27K | Hold |
60
| – | – | ﹤0.01% | 453 |
|
|
2023
Q2 | $6.87K | Hold |
60
| – | – | ﹤0.01% | 450 |
|
|
2023
Q1 | $8.27K | Hold |
60
| – | – | ﹤0.01% | 434 |
|
|
2022
Q4 | $7.78K | Hold |
60
| – | – | ﹤0.01% | 436 |
|
|
2022
Q3 | $7K | Hold |
60
| – | – | ﹤0.01% | 433 |
|
|
2022
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 449 |
|
|
2022
Q1 | $5K | Hold |
60
| – | – | ﹤0.01% | 458 |
|
|
2021
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 453 |
|
|
2021
Q3 | $6K | Hold |
60
| – | – | ﹤0.01% | 409 |
|
|
2021
Q2 | $5K | Buy |
+60
| New | +$5K | ﹤0.01% | 452 |
|